Randall H Gholson

Array ( [id] => 3619015 [patent_doc_number] => 05601823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Avian antitoxins to clostridium difficle toxin A' [patent_app_type] => 1 [patent_app_number] => 8/161907 [patent_app_country] => US [patent_app_date] => 1993-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27206 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601823.pdf [firstpage_image] =>[orig_patent_app_number] => 161907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3683162 [patent_doc_number] => 05643572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Methods and compositions for the modulation of host immune response to an allergen' [patent_app_type] => 1 [patent_app_number] => 8/157843 [patent_app_country] => US [patent_app_date] => 1993-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8395 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643572.pdf [firstpage_image] =>[orig_patent_app_number] => 157843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3598039 [patent_doc_number] => 05578287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Three-step pretargeting methods using improved biotin-active agent' [patent_app_type] => 1 [patent_app_number] => 8/156614 [patent_app_country] => US [patent_app_date] => 1993-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19611 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578287.pdf [firstpage_image] =>[orig_patent_app_number] => 156614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3116472 [patent_doc_number] => 05410025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-25 [patent_title] => 'Unmodified intravenously administered immunoglobulin preparations containing immunoglobulin M and/or A' [patent_app_type] => 1 [patent_app_number] => 8/154149 [patent_app_country] => US [patent_app_date] => 1993-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2354 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/410/05410025.pdf [firstpage_image] =>[orig_patent_app_number] => 154149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3585569 [patent_doc_number] => 05585097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Humanized anti-CD3 specific antibodies' [patent_app_type] => 1 [patent_app_number] => 7/988925 [patent_app_country] => US [patent_app_date] => 1993-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 9287 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585097.pdf [firstpage_image] =>[orig_patent_app_number] => 988925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3717593 [patent_doc_number] => 05616690 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Hexose derivatized human serum albumin clearing agents' [patent_app_type] => 1 [patent_app_number] => 8/133613 [patent_app_country] => US [patent_app_date] => 1993-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25536 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616690.pdf [firstpage_image] =>[orig_patent_app_number] => 133613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630637 [patent_doc_number] => 05630996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Two-step pretargeting methods using improved biotin-active agent conjugates' [patent_app_type] => 1 [patent_app_number] => 8/122979 [patent_app_country] => US [patent_app_date] => 1993-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 43625 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/630/05630996.pdf [firstpage_image] =>[orig_patent_app_number] => 122979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3505882 [patent_doc_number] => 05569602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-29 [patent_title] => 'First immortalized Kaposi\'s sarcoma cell line' [patent_app_type] => 1 [patent_app_number] => 8/110175 [patent_app_country] => US [patent_app_date] => 1993-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7574 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/569/05569602.pdf [firstpage_image] =>[orig_patent_app_number] => 110175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768282 [patent_doc_number] => 05849583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease' [patent_app_type] => 1 [patent_app_number] => 8/110348 [patent_app_country] => US [patent_app_date] => 1993-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 12694 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849583.pdf [firstpage_image] =>[orig_patent_app_number] => 110348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3102377 [patent_doc_number] => 05417972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-23 [patent_title] => 'Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM' [patent_app_type] => 1 [patent_app_number] => 8/101436 [patent_app_country] => US [patent_app_date] => 1993-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3591 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/417/05417972.pdf [firstpage_image] =>[orig_patent_app_number] => 101436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998974 [patent_doc_number] => 05858725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Preparation of chimaeric antibodies using the recombinant PCR strategy' [patent_app_type] => 1 [patent_app_number] => 8/039198 [patent_app_country] => US [patent_app_date] => 1993-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10180 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 451 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858725.pdf [firstpage_image] =>[orig_patent_app_number] => 039198 [rel_patent_id] =>[rel_patent_doc_number] =>)